// App-Quantinova.ai

76 : Immune-related adverse event (irAE) education, self-efficacy, and potential irAE experiences in patients treated with immunotherapy for non-small cell lung cancer (NSCLC).

Researchers

Presenter

  • Urvi Mujumdar

Principal Investigators

  • Huifen Wang

  • Elizabeth Lawler

  • Victoria Lanzarini

  • Maria Lowe

  • Nataliya Trunova

  • Alyssa B. Klein

  • Cathy Emmas

Medical Centers

  • PatientsLikeMe, Cambridge, MA

  • AstraZeneca, Gaithersburg, MD

  • AstraZeneca, Royston, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A